Manchester Breast Centre
Manchester Firsts
First clinical use of tamoxifen - Moya Cole and Ian Todd (1969)
First pre-surgical use of tamoxifen - Andrew Baildam and Tony Howell (1987)
About Us
There have been extraordinary advancements in breast cancer research leading to great improvements in patient treatment and care over the past two decades. Manchester is a key player in the efforts to progress research and build on past achievements in the field. The Manchester Breast Centre (MBC) is therefore vital in driving breast cancer research forward.
The mission of the MBC is to create a world-class centre for basic and translational breast cancer research, leading to effective detection and treatment of women at risk, and ultimately elimination of the disease. In 2005 the Centre underwent a peer review and following this a phase of expansion. The MBC currently consists of 17 Principal Investigators and is directed by Professor Gareth Evans, Consultant in Medical Genetics and Cancer Epidemiology at Central Manchester Hospitals NHS Foundation Trust.
The aim of the MBC is to enhance research in breast biology and breast disease through collaboration and two major units are incorporated: the Genesis Prevention Centre, which was established in 2009 and is based at University Hospital of South Manchester in Wythenshawe, and the Breakthrough Breast Cancer Unit, which is located at the Paterson Institute for Cancer Research.